Note: This document contains side effect information about sulfacetamide sodium ophthalmic. Some dosage forms listed on this page may not apply to the brand name Bleph-10.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
Side effects include:
Local irritation, transient stinging or burning.
For Healthcare Professionals
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.
General
The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]
Ocular
Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]
Hypersensitivity
Rare (less than 0.1%): Sensitivity reactions
Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]
At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]
Other
Frequency not reported: Secondary infections[Ref]
Dermatologic
Sulfonamides:
-Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).
Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]
Hematologic
Sulfonamides:
-Frequency not reported: Agranulocytosis, aplastic anemia, other blood dyscrasias[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
Hepatic
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
Sulfonamides:
-Frequency not reported: Fulminant hepatic necrosis[Ref]
